Hence, all evidence supporting the pathogenicity of RELN variants identified in the pachygyria patients reflects deficient levels of functional RELN in their developing neocortex that potentially disrupt RELN-dependent neuronal migration from its early steps. This evidence concerns the gene RELN and Pachygyria.